MTOR and colorectal cancer: The mTOR inhibitor dactolisib (BEZ-235), in combination with BMS-1166, promotes apoptosis in colorectal cancer cells by blocking the PI3K/mTOR pathway and disrupting the crosstalk of the MAPK pathway (46).